Virginia Tech: Leukemia Study Highlights Need to Standardize Testing
September 16, 2026
September 16, 2026
BLACKSBURG, Virginia, Sept. 16 (TNSjou) -- Virginia Tech issued the following news:
* * *
Leukemia study highlights need to standardize testing
Research led by Fralin Biomedical Research Institute scientists found that the usefulness of a widely used measure of acute myeloid leukemia relapse risk depends on who is doing the test.
By Leigh Anne Kelley 15 Sep 2026
Multiparametric flow cytometry -- a test that is widely accessible, co . . .
* * *
Leukemia study highlights need to standardize testing
Research led by Fralin Biomedical Research Institute scientists found that the usefulness of a widely used measure of acute myeloid leukemia relapse risk depends on who is doing the test.
By Leigh Anne Kelley 15 Sep 2026
Multiparametric flow cytometry -- a test that is widely accessible, co . . .